bpc 157 clinical trial human safety BPC-157 is being marketed as a “healing peptide” for tendon injuries, joint pain, gut repair, inflammation, and recovery. The problem is that “healing” biology is not always simple in people with cancer BPC-157 General Info Sheet
Description
The condition affects roughly 1 to 3% of the general adult population, with peak incidence occurring between ages 30 and 50
Perhaps you need a metabolism, weight loss, energy, and hangover IV drip treatment
REGEN is supplied as lyophilized (freeze-dried) powder in sterile vials containing 10 mg total peptide content (5 mg BPC-157 + 5 mg TB-500)
Dermatology online journal, 21(9), 13030/qt8kw141mb
